News

HDA UK Media And Political Bulletin – 11 December 2017

Media and Political Bulletin

9 December 2017

A reminder to all members that the CAPPI Symposium in partnership with the GIRP conference ‘Supply chain to value chain: Together adding value’, will be held on Wednesday 21 March 2018. Too see full details, please click here.

The GIRP press review for 1-8 December 2017, is now available to view. To read the full report, please follow this link.

Media Summary

Pharmaceutical industry welcomes breakthrough on ‘sufficient progress’ in Brexit negotiations

ABPI, 8 December 2017

 

Following the announcement from European Commission President Jean-Claude Juncker and Prime Minister Theresa May on the 8th December, reporting that ‘sufficient progress’ has been agreed on phase one of the Brexit negotiations, the ABPI released the following statement:

“The breakthrough on ‘sufficient progress’ reached between the UK and the EU this morning is a significant step forwards and one we warmly welcome.

“The progress made on citizens’ rights is particularly welcome news for pharmaceutical companies and our employees. To provide certainty to everyone, we hope this is swiftly agreed.

“As we now focus on phase two of the negotiations, it is now crucial that the regulation and supply of medicines for UK and EU patients is prioritised. A cooperation agreement between the UK and the EU on medicines is the best way to ensure that there is no disruption to 500m patients receiving the medicines that they need.​

“This breakthrough, alongside a single-step fixed-term transition period that allows companies to make any necessary changes to the supply chain, will be critical. Protecting public health in the UK and Europe must be a priority.”

 

 

Parliamentary Coverage

 

There is no parliamentary coverage today.

 

Full Coverage

Pharmaceutical industry welcomes breakthrough on ‘sufficient progress’ in Brexit negotiations

ABPI, 8 December 2017

 

Following an announcement from European Commission President Jean-Claude Juncker and Prime Minister Theresa May this morning [8 December] that ‘sufficient progress’ has been agreed on phase one of the Brexit negotiations, the ABPI has released the following statement.

“The breakthrough on ‘sufficient progress’ reached between the UK and the EU this morning is a significant step forwards and one we warmly welcome.

“The progress made on citizens’ rights is particularly welcome news for pharmaceutical companies and our employees. To provide certainty to everyone, we hope this is swiftly agreed.

“As we now focus on phase two of the negotiations, it is now crucial that the regulation and supply of medicines for UK and EU patients is prioritised. A cooperation agreement between the UK and the EU on medicines is the best way to ensure that there is no disruption to 500m patients receiving the medicines that they need.​

“This breakthrough, alongside a single-step fixed-term transition period that allows companies to make any necessary changes to the supply chain, will be critical. Protecting public health in the UK and Europe must be a priority.”

HDA UK Media And Political Bulletin – 11 December 2017

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?